Pediatric Rheumatology

pediatric rheumatology banner

Latest News

Clinical Assessment of Juvenile Idiopathic Arthritis: Predicting Unfavorable Long-Term Outcomes

Clinical Assessment of Juvenile Idiopathic Arthritis: Predicting Unfavorable Long-Term Outcomes

Prediction models of outcomes in juvenile idiopathic arthritis have acceptable precision and require only readily available baseline variables.

Clinical Correlates of JIA Relapse After Biologic Therapy Discontinuation

Clinical Correlates of JIA Relapse After Biologic Therapy Discontinuation

The investigators sought to evaluate the time patients were in remission after discontinuing biologic therapy for the treatment of JIA.

Actemra SC Approved to Treat Polyarticular Juvenile Idiopathic Arthritis

Actemra SC Approved to Treat Polyarticular Juvenile Idiopathic Arthritis

The FDA has approved the subcutaneous formulation of Actemra for the treatment of active polyarticular juvenile idiopathic arthritis.

Depressive Symptoms Predict Future Pain, Disability in Adolescent JIA

Depressive Symptoms Predict Future Pain, Disability in Adolescent JIA

Baseline depressive symptoms were associated with pain and disability in adolescents with juvenile idiopathic arthritis.

Efficacy, Safety of Adalimumab vs Infliximab in JIA-Associated Uveitis

Efficacy, Safety of Adalimumab vs Infliximab in JIA-Associated Uveitis

Researchers evaluated the safety and efficacy of adalimumab and infliximab in the treatment of juvenile idiopathic arthritis-associated uveitis in patients treated for at least 2 years.

Amendment Added to OMERACT Ultrasound Definition of Healthy Pediatric Joints

Amendment Added to OMERACT Ultrasound Definition of Healthy Pediatric Joints

Researchers sought to include Doppler findings in the evaluation and definition of normal joint features that can be visualized in healthy children in different age groups.

Treatment Targets in JIA: Comparing Definitions of Clinically Inactive Disease

Treatment Targets in JIA: Comparing Definitions of Clinically Inactive Disease

Investigators aimed to examine the use of treatment targets in juvenile idiopathic arthritis in terms of joint limitations, functional ability, psychosocial health, and pain levels.

Managing Uveitis in Juvenile Idiopathic Arthritis: Consensus-Based Recommendations

Managing Uveitis in Juvenile Idiopathic Arthritis: Consensus-Based Recommendations

The SHARE initiative has provided recommendations for the diagnosis and treatment of juvenile idiopathic arthritis-associated uveitis.

Clinical Features Identified in Enthesitis-Related Juvenile Idiopathic Arthritis, Juvenile Spondyloarthritis

Clinical Features Identified in Enthesitis-Related Juvenile Idiopathic Arthritis, Juvenile Spondyloarthritis

Results confirm that juvenile spondyloarthritis is characterized by its peripheral pattern at disease onset, with peripheral arthritis and enthesitis.

Genetic Risk Loci Found Within Disease Phenotypes Including SLE, JIA

Genetic Risk Loci Found Within Disease Phenotypes Including SLE, JIA

The Epstein-Barr virus EBNA2 protein and many coclustering human transcription factors occupied nearly half of SLE risk loci.

Sign Up for Free e-newsletters